CompaniesModern Biosciences

Modern Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

BankruptRebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

522

By Phase

PHASE1: 2PHASE2: 3

By Status

COMPLETED: 3RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT03139136
Hover over trial bars to see details

Recent Trials

NCT06379958Lead Sponsor
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
PHASE1Recruiting
48 participants
Started: Apr 8, 2024 · Completed: Sep 30, 2024
NCT05951296Lead Sponsor
A Study to Investigate Leramistat in Patients With IPF
PHASE2Withdrawn
Started: Aug 30, 2023 · Completed: Mar 14, 2024
NCT05460832Lead Sponsor
Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA
PHASE2Completed
248 participants
Started: Aug 29, 2022 · Completed: Jan 3, 2024
NCT03139136Lead Sponsor
Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis
PHASE2Completed
121 participants
Started: May 30, 2017 · Completed: Aug 13, 2019
NCT02480946Lead Sponsor
Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis
PHASE1Completed
105 participants
Started: Jul 31, 2015 · Completed: Mar 31, 2017